These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 6202923
1. Suppression of natural killer cell activity by Friend murine leukemia virus. Moody DJ, Specter S, Bendinelli M, Friedman H. J Natl Cancer Inst; 1984 Jun; 72(6):1349-56. PubMed ID: 6202923 [Abstract] [Full Text] [Related]
3. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes. Holmes KV, Welsh RM, Haspel MV. J Immunol; 1986 Feb 15; 136(4):1446-53. PubMed ID: 3003198 [Abstract] [Full Text] [Related]
4. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice. Brunda MJ, Taramelli D, Holden HT, Varesio L. J Immunol; 1983 Apr 15; 130(4):1974-9. PubMed ID: 6187831 [Abstract] [Full Text] [Related]
5. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice. Tonietti G, Rossi GB, Del Gobbo V, Accinni L, Ranucci A, Titti F, Premrov MG, Garaci E. Cancer Res; 1983 Sep 15; 43(9):4355-63. PubMed ID: 6347370 [Abstract] [Full Text] [Related]
6. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice. Afifi MS, Bennett M, Kumar V. Nat Immun Cell Growth Regul; 1986 Sep 15; 5(4):200-10. PubMed ID: 2430178 [Abstract] [Full Text] [Related]
8. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice. Collavo D, Zanovello P, Biasi G, Chieco-Bianchi L. J Immunol; 1981 Jan 15; 126(1):187-93. PubMed ID: 6969741 [Abstract] [Full Text] [Related]
9. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells. Hsu KH, Friedman H. J Natl Cancer Inst; 1985 Jul 15; 75(1):105-10. PubMed ID: 3859684 [Abstract] [Full Text] [Related]
10. Enhancement of erythroid target cells for Friend murine leukemia virus by intravenous pyran treatment. Schuller GB, Morahan PS. J Natl Cancer Inst; 1979 May 15; 62(5):1257-60. PubMed ID: 286101 [Abstract] [Full Text] [Related]
11. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection. Stein-Streilein J, Bennett M, Mann D, Kumar V. J Immunol; 1983 Dec 15; 131(6):2699-704. PubMed ID: 6644021 [Abstract] [Full Text] [Related]
14. Immunotherapy of murine leukemia. VIII. Efficacy of passive serum therapy of Friend leukemia virus-induced disease in immunocompromised mice. Genovesi EV, Livnat D, Collins JJ. J Natl Cancer Inst; 1983 Feb 15; 70(2):311-22. PubMed ID: 6337292 [Abstract] [Full Text] [Related]
15. Synergistic effect of human lactoferrin and recombinant murine interferon-gamma on disease progression in mice infected with the polycythemia-inducing strain of the Friend virus complex. Lu L, Shen RN, Zhou SZ, Srivastava C, Harrington M, Miyazawa K, Wu B, Lin ZH, Ruscetti S, Broxmeyer HE. Int J Hematol; 1991 Apr 15; 54(2):117-24. PubMed ID: 1660735 [Abstract] [Full Text] [Related]